Devon Langbein

Devon Langbein is a Principal Associate Scientist at AbbVie since August 2024, following the company's acquisition of Cerevel Therapeutics, where Langbein held the same title from March 2022 to August 2024. At Cerevel, Langbein supported small molecule drug substance and solid oral dosage form drug product analytical development, conducting investigations, managing outsourced activities, and reviewing analytical protocols and data reports. Prior to Cerevel, Langbein worked at GATTEFOSSÉ as an Application Laboratory Analytical Scientist and Technical Service Coordinator, focusing on analytical and formulation experiments for pharmaceutical dosage forms and providing technical support to customers. Langbein began a career at Product Safety Labs as a Study Director and Analytical Chemist, responsible for conducting GLP-compliant analytical studies and ensuring data integrity. Langbein earned a Bachelor's Degree in Chemistry from Cornell University in 2015.